MORGAN STANLEY - 31 Mar 2025 SCHEDULE 13G/A Report for Syndax Pharmaceuticals Inc Common Stock (SNDX)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: Syndax Pharmaceuticals Inc Common Stock
Symbol: SNDX
Shares outstanding: 85,000,542 shares
Disclosed Ownership: 2,040,013 shares
Ownership: 2.4%
Form type: SCHEDULE 13G/A
Filing time: 07 May 2025, 11:25:22 UTC
Date of event: 31 Mar 2025
Previous filing: 05 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	2.4%	2,040,013	0	1,994,022	Chris O'Hara	Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC	0.2%	213,174	0	213,174	Chris O'Hara	Authorized Signatory, Morgan Stanley & Co. LLC